Menopause brain fog (forgetfulness, trouble concentrating, a sense of thinking more slowly) is real and common: according to the U.S. government, as many as two-thirds of women in perimenopause report problems with memory or focus. In the SWAN study, which followed more than 2,000 women, it was temporary on average. Several things that make it worse, such as poor sleep, depression or low vitamin B12, can be treated. Hormone therapy is not FDA-approved for memory or to prevent dementia. See a doctor if forgetfulness affects your daily life, and call 911 for sudden confusion.
What menopause brain fog is
"Brain fog" is not a diagnosis. It is how many women describe forgetfulness, trouble concentrating or the sense that learning takes more effort. The National Institute on Aging (NIA) lists forgetfulness and difficulty concentrating among the symptoms of the menopausal transition, which usually begins between ages 45 and 55.
Why it happens
The brain has many estrogen receptors, for example in the hippocampus, which is why researchers suspect that falling estrogen affects memory. SWAN supports an effect of the transition itself: on repeated tests, premenopausal women improved with practice, but in perimenopause that improvement was not seen.
Other factors add up. In SWAN, depressive symptoms were linked to slower processing speed, anxiety symptoms to less learning and, in early postmenopause, fragmented sleep to slower speed. Other studies link objectively measured hot flashes to memory problems. Even so, these symptoms did not explain the temporary dip in learning in late perimenopause.
Is it temporary? Is it dementia?
In SWAN, the ability to improve with practice returned, on average, after menopause. Dementia is different: the NIA describes it as a loss of thinking, remembering and reasoning that interferes with daily life, and notes that it is not a normal part of aging. See a doctor if you:
- ask the same questions over and over;
- get lost in places you used to know well;
- have trouble following recipes or directions;
- become more confused about time, people or places.
Other causes worth ruling out
Brain fog does not always come from hormones. The NIA lists other causes of memory problems; when a medical condition is the cause, the problems usually go away once it is treated:
- Sleep. Lack of sleep can make you more forgetful. Sleep apnea makes learning and focusing harder, and according to the NIH, fatigue, headache and insomnia from apnea are more common in women.
- Thyroid. Hypothyroidism is much more common in women and can cause fatigue, depression and heavy or irregular periods.
- Vitamin B12. Low B12 can cause problems concentrating; long-term use of metformin or antacids raises the risk.
- Iron. Iron deficiency anemia can cause tiredness and problems concentrating; heavy or frequent periods are a common cause.
- Mood. Depression, including perimenopausal depression, and anxiety affect concentration and memory.
- Medicines and alcohol. Medication side effects and alcohol or drug misuse also count.
Depending on your symptoms, your doctor may consider tests such as TSH (thyroid), a complete blood count, ferritin (iron stores) and vitamin B12.
What helps
- Protect your sleep. The NIA generally recommends seven to eight hours a night. If you snore, wake up gasping or wake up tired, ask about a sleep study.
- Treat hot flashes that wake you. Hormone therapy is the most effective treatment for hot flashes, and The Menopause Society also recommends nonhormone options, such as cognitive behavioral therapy, clinical hypnosis and some medicines.
- Look after your mood. Depression is typically treated with psychotherapy, medication or both.
- Use practical supports. Routines, lists, calendars and one fixed spot for your keys and phone.
- Watch your blood pressure, blood sugar and weight. In SWAN, high blood pressure, elevated glucose and obesity were linked to a faster decline in processing speed; whether controlling them slows that decline is still being studied.
- Be wary of "memory" products. The NIA warns they may be unsafe, a waste of money, or both.
Hormone therapy and memory: what the FDA changed and what it didn't
On November 10, 2025, the FDA asked for cardiovascular disease, breast cancer and probable dementia language to be removed from the boxed warning on menopause hormone therapy, and for the probable dementia warning to be removed from the label entirely. On February 12, 2026, it approved the first six updated labels. The FDA explained that the Women's Health Initiative dementia studies enrolled women aged 65 to 79, much older than women who typically start therapy; in those studies, according to The Menopause Society, starting estrogen plus progestin raised dementia risk by about 23 cases per 10,000 women per year. Cardiovascular and breast cancer risks remain in the label's Warnings and Precautions.
Removing a warning is not the same as showing a benefit. In menopause, hormone therapy is approved for moderate to severe hot flashes, vaginal dryness and discomfort, and prevention of bone loss, not for memory or dementia prevention. The November announcement cited a possible reduction in Alzheimer's disease; that is not an approved use. The Menopause Society does not recommend hormone therapy at any age to prevent or treat cognitive decline or dementia, and considers its cognitive effects neutral when started soon after natural menopause. It notes only a possible benefit of estrogen started right after removal of the uterus and both ovaries.
Hormone therapy may improve insomnia in some women, and treating hot flashes that disrupt sleep is an approved use. All hormone therapy carries risks. These changes apply only to FDA-approved products: compounded "bioidentical hormones" are not FDA-approved. For more, see what the FDA's label change means and menopause hormone therapy in Miami.
When to see a doctor, and when it's urgent
Book a visit if forgetfulness affects your daily life, if the changes are obvious or sudden, if you notice any of the signs above, or if you also snore loudly, feel sad most of the time or have very heavy periods. For a full evaluation, see brain fog and cognitive health care in Miami.
Call 911 if you suddenly have confusion, trouble speaking, numbness or weakness of the face, an arm or a leg, trouble seeing, loss of balance, or a severe headache with no known cause: these can be signs of a stroke. If you have thoughts of suicide, call or text 988; help is also available in Spanish.
What the research says
Each citation links to the original source.
- SWAN, cohort study
- Population: 2,362 midlife women in the U.S., followed for 4 years.
- Details: repeated tests of processing speed and memory, compared by menopause stage.
- Result: in perimenopause, women did not improve with practice as before; after menopause, they did. The difficulties "may be time-limited."
- Limits: observational; its hormone-use findings have not been confirmed in randomized trials.
- Citation: Greendale GA, Huang MH, Wight RG, et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology. 2009;72(21):1850-1857. https://doi.org/10.1212/WNL.0b013e3181a71193
- KEEPS-Cog, randomized trial
- Population: 693 healthy women, average age 52.6, 1.4 years past their last period.
- Details: oral conjugated estrogens, an estradiol patch or placebo, with cyclic progesterone, for up to 4 years.
- Result: hormone therapy "did not alter cognition"; the oral form modestly improved depression and anxiety symptoms.
- Limits: healthy women at low cardiovascular risk, not selected for brain fog; about a quarter missed later cognitive assessments.
- Citation: Gleason CE, Dowling NM, Wharton W, et al. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. PLoS Med. 2015;12(6):e1001833. https://doi.org/10.1371/journal.pmed.1001833
- ELITE-Cog, randomized trial
- Population: 567 healthy women, less than 6 years or 10 or more years past menopause.
- Details: oral estradiol 1 mg a day or placebo, for 57 months on average.
- Result: no effect on verbal memory, executive function or global cognition, whether started early or late: estradiol "neither benefits nor harms" these abilities.
- Limits: one type of estrogen; perimenopause was not studied.
- Citation: Henderson VW, St John JA, Hodis HN, et al. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis. Neurology. 2016;87(7):699-708. https://doi.org/10.1212/WNL.0000000000002980
Talk to Elizabeth Isalguez, MD, about brain fog
Bring a two-week log (fog, sleep, hot flashes and periods) and a list of all your medicines and supplements. At Organic Well in Coconut Grove, care is led by Elizabeth Isalguez, MD, an internal medicine physician, and brain fog is treated as a symptom to investigate, starting with common, treatable causes. Visits are by appointment at 3661 S. Miami Ave, Suite 1003.
Book a visit or call (305) 930-8891, Monday to Friday, 9 AM to 6 PM.
